Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
81 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
BeOne Medicines Belgium from Brussel, company number BE1001115521, closed financial year 2025 with a result of € 377,994 after tax. For that financial year BeOne Medicines Belgium recorded a gross margin of € 4.6 million and equity of € 651,796. Compared with financial year 2024, the result moved from € 223,802 to € 377,994. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 651,796
▲ 138% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 377,994
▲ 69% vs 2024
Profit after tax over the fiscal year.
€ 1.5 million
▲ 128% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 601,796.
People and assets in 2025
12.5
▲ 1.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 4 million
▲ 97% vs 2024
€ 323,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 437,586
▼ 45% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1.3 million
▲ 108% vs 2024
Taxes, VAT and social contributions still to pay.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 2,422,906 | € 4,600,300 | ▲ 90% |
| Profit after taxes | € 223,802 | € 377,994 | ▲ 69% |
| Equity | € 273,802 | € 651,796 | ▲ 138% |
| Total debts | € 1,491,797 | € 1,780,818 | ▲ 19% |
| Cash | € 647,361 | € 1,475,748 | ▲ 128% |
| Retained profit | € 223,802 | € 601,796 | ▲ 169% |
| Balance sheet total | € 1,765,599 | € 2,432,614 | ▲ 38% |
| Employees (FTE) | 10.9 | 12.5 | ▲ 1.6 |
By gross margin, BeOne Medicines Belgium ranks 1st of 22 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Brussel that publish figures (fiscal year 2025).
Key figures of BeOne Medicines Belgium, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about BeOne Medicines Belgium the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to BeOne Medicines Belgium?
What happened at BeOne Medicines Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 377,994 (▲ 69% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Brussel. KBO
- Pierre MALPOT became a director. NBB
- Sandro DE ANGELIS became a director. NBB
- Carole Coudray became a director. NBB
In short
From € 223,802 profit in 2024 to € 377,994 profit in 2025.
Paid € 314,205 in corporate taxes since 2024.
Best year ever: 2025, with € 377,994 profit.
On average € 368,000 of value added per employee in 2025.
Management
Behind BeOne Medicines Belgium are Pierre MALPOT, Sandro DE ANGELIS and Carole Coudray.
Directors
According to the 2025 annual accounts
Pierre MALPOT
Director
since 2023
Sandro DE ANGELIS
Director
since 2023
Carole Coudray
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Wolstraat 70
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 81 companies are registered at this address.
All companies at this address →finance&invest.brussels
€ 20,250 revenue · 2025
IMMOWEB
€ 61.3 million revenue · 2025
KORN FERRY (BE)
€ 25.5 million revenue · 2026
BRUXELLES INFRASTRUCTURE FINANCE - BRUSSEL INFRASTUCTUUR FINANCIERING
€ 717,081 revenue · 2025
BRUSTART BY FINANCE&INVEST.BRUSSELS
+76 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brussel
Same main activity (Groothandel in farmaceutische en medische artikelen), 30 active companies in Brussel, largest first.
€ 326.9 million revenue · 2025
€ 294.3 million revenue · 2025
VERTEX PHARMACEUTICALS (BELGIUM)
€ 88.9 million revenue · 2025
€ 71.3 million revenue · 2025
€ 20.8 million revenue · 2025
€ 18.7 million revenue · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- BeiGene Switzerland Gmbh(oprichter) 100%
Details
- Company number
- 1001.115.521
- VAT number
- BE 1001.115.521
- Registered office
- Wolstraat 70, 1000 Brussel
- Names & denominations
- BeOne Medicines Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 October 2023
- Peppol
- Active · Active since 19 Nov 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen